South Burlington, VT, United States of America

Martin M Bednar


Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 79(Granted Patents)


Location History:

  • North Stonington, CT (US) (2000 - 2005)
  • South Burlington, VT (US) (1998 - 2010)

Company Filing History:


Years Active: 1998-2010

Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Martin M Bednar - Innovator in Stroke Treatment**

Introduction

Martin M Bednar is an esteemed inventor based in South Burlington, Vermont, known for his significant contributions to medical advancements, particularly in the realm of stroke treatment. With a commendable portfolio of nine patents, he has made strides toward improving clinical outcomes in focal ischemic stroke.

Latest Patents

Among his most notable patents, two innovative methods stand out. The first, titled "Co-administration of a tissue plasminogen activator, anti-CD11b antibody and anti-CD18 antibody in stroke," details a method for enhancing clinical outcomes in focal ischemic stroke in mammals. This process involves administering an effective amount of an anti-CD18 antibody to the mammal, aimed at increasing cerebral blood flow and/or reducing infarct size without the necessity of removing the arterial obstruction. The second patent, "Co-administration of a thrombolytic and an anti-CD18 antibody in stroke," similarly seeks to improve outcomes by employing the same administration technique, emphasizing the absence of arterial obstruction removal.

Career Highlights

Bednar has garnered extensive experience through his professional engagements with prominent organizations such as Genentech, Inc., and the University of Vermont and State Agricultural College. His work in these institutions has played a crucial role in advancing research and technological pipelines aimed at dealing with stroke-related complications.

Collaborations

Throughout his career, Martin M Bednar has collaborated with notable coworkers, including Cordell E Gross and Michael Balazy. These partnerships have facilitated the development of his innovative approaches and have contributed to the success of his patent applications.

Conclusion

Martin M Bednar exemplifies the spirit of innovation in the medical field, with his research and patents focusing on enhancing treatment options for stroke patients. His contributions not only highlight his dedication to improving healthcare but also underscore the vital importance of collaboration in the innovation process.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…